The future of targeted alpha therapy development and manufacture
Following the first industrial-scale facility for targeted alpha therapy (TAT) production in Europe beginning construction, in this exclusive Q&A, Julien...
Cancer Therapy Development
FogPharma secures $145m to support cancer therapy development
The investment will enhance the company’s data science expertise and bolster its Helicon therapeutics platform. Credit: Likoper / Shutterstock.com. FogPharma...
Breast cancer
Key factsBreast cancer caused 670 000 deaths globally in 2022.Roughly half of all breast cancers occur in women with no specific...
From discovery to clinical-ready solutions
Since the FDA first approved CAR-T cell therapy in 2017, eight CAR-T drugs have emerged, six of which have been...
Experts Forecast 2024, Part 3: Precision Medicine
In anticipation of the new year, we asked four experts to predict the advances we might see in 2024 in...
Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies
UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue,...
